AI assistant
Elbit Imaging-M Ltd. Capital/Financing Update 2018
6760_rns_2018-06-07_d00f4f80-5fee-4576-9cc9-9170e9a53b58.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
ELBIT IMAGING LTD. ANNOUNCES FULL REDEMPTION OF ITS SERIES H NOTES
Tel Aviv, Israel, June 5, 2018, Elbit Imaging Ltd. (TASE, NASDAQ: EMITF) ("Elbit" or the "Company") announced today, that on May 31, 2018 it completed the full redemption of its series H notes.
About Elbit Imaging Ltd.
Elbit Imaging Ltd. operates in the following principal fields of business: (i) Medical Industries through our indirect holdings in InSightec Ltd. and Gamida Cell Ltd.; (ii) Plots in India which are designated for sale (and which were initially designated for residential projects); (iii) Plots in Eastern Europe which are designated for sale (and which were initially designated for development of commercial centers).
For Further Information: Company Contact Ron Hadassi CEO and Chairman of the Board of Directors Tel: +972-3-608-6048 Fax: +972-3-608-6050 [email protected]